Pfizer to Postpone Some Drug Price Increases, After Criticism From Trump

By ROBERT PEAR
NYT Politics
The company said it would roll back increases that took effect July 1 to give the president a chance to work on his “blueprint” to lower prices and to “provide more access for patients.”
Published date: July 11, 2018 at 06:35AM
The New York Times
New York Times article